Immune Factors Drive Expression of SARS-CoV-2 Receptor Genes Amid Sexual Disparity

• Published in: Viruses 2023-02, Vol.15 (3), p.657
• Main Authors: Vashisht, Ashutosh, Ahluwalia, Pankaj, Mondal, Ashis K, Singh, Harmanpreet, Sahajpal, Nikhil S, Fulzele, Sadanand, Kota, Vamsi, Gahlay, Gagandeep K, Kolhe, Ravindra
• Format: Article
• Language: English
• Subjects: ACE2; Analysis; Angiotensin-converting enzyme 2; Angiotensin-Converting Enzyme 2 - genetics; Angiotensin-Converting Enzyme 2 - metabolism; Animals; coronavirus; Coronaviruses; COVID-19; COVID-19 - genetics; Disease susceptibility; Female; Humans; Immune response; Immunity; Immunologic Factors; Influence; Interferon regulatory factor 7; Interferon Regulatory Factors - metabolism; Male; Mice; Morbidity; Mortality; Pandemics; Patients; Peptidyl-Dipeptidase A - metabolism; Risk factors; SARS-CoV-2; SARS-CoV-2 - genetics; SARS-CoV-2 - metabolism; Severe acute respiratory syndrome coronavirus 2; Sex (Biology); Sex differences; TLR7 protein; Toll-like receptors; Vaccination
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v15030657

The emergence of COVID-19 has led to significant morbidity and mortality, with around seven million deaths worldwide as of February 2023. There are several risk factors such as age and sex that are associated with the development of severe symptoms due to COVID-19. There have been limited studies that have explored the role of sex differences in SARS-CoV-2 infection. As a result, there is an urgent need to identify molecular features associated with sex and COVID-19 pathogenesis to develop more effective interventions to combat the ongoing pandemic. To address this gap, we explored sex-specific molecular factors in both mouse and human datasets. The host immune targets such as TLR7, IRF7, IRF5, and IL6, which are involved in the immune response against viral infections, and the sex-specific targets such as AR and ESSR were taken to investigate any possible link with the SARS-CoV-2 host receptors ACE2 and TMPRSS2. For the mouse analysis, a single-cell RNA sequencing dataset was used, while bulk RNA-Seq datasets were used to analyze the human clinical data. Additional databases such as the Database of Transcription Start Sites (DBTS), STRING-DB, and the Swiss Regulon Portal were used for further analysis. We identified a 6-gene signature that showed differential expression in males and females. Additionally, this gene signature showed potential prognostic utility by differentiating ICU patients from non-ICU patients due to COVID-19. Our study highlights the importance of assessing sex differences in SARS-CoV-2 infection, which can assist in the optimal treatment and better vaccination strategies.